Rebalix
Amundi · sheet of 20 October 2026
Amundi · sheet of 20 October 2026ETF sheet · official issuer and register data
Amundi Gold Miners UCITS ETF Dist
CD91 · LU2611731824 · class UCITS ETF Dist · USD · domicile Luxembourg
Equity · Global · Gold & silver miners · ThematicSFDR art. 6
Index tracked: Solactive Developed Markets Pure Gold Miners Index NTR
- TER
- 0.65%+ trans. 0.01%
- Fund size
- 727 m EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingannual
Launch 7 Dec 2023 · costs from the KID as of 2 Oct 2026 · 30 securities held · 4 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The Solactive Developed Markets Pure Gold Miners Index is an equity index which represents global gold mining equities. Eligible companies must be classified as Developed Markets under the Solactive Global Benchmark Series or as Emerging Market companies listed via ADRs. Additionally, the company’s index category must be Gold Mining. The Index is a Net Total Return index. A net total return index calculated the performance of the index constituents on the basis that any dividends or distributions are reinvested net of…
Performance since series start (in euro) — base 100
29 Nov 2023 → 15 Oct 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +18.2% |
| 3 years | +200.3% |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +200.3% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 49.05% | 49.05% | — |
| Max drawdown | −39.31% | −39.31% | — |
| Sharpe | 0.36 | 0.36 | — |
| Sortino | 0.50 | 0.50 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CD91 · LU26117318241
RebalixCD91 · LU2611731824 · sheet of 20 October 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +155.04% | +156.73% | −1.69% |
| 2024 | +13.79% | +14.57% | −0.78% |
Distributions · per share, in USD
Frequency: annual · last 12 months: 0.11 USD (0.15% of NAV) · last ex-date 9 Dec 2025
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2025 | 1 | 0.11 | +0.41% |
| 2024 | 1 | 0.09 | +0.38% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 30 Sept 2026 · 30 securities · top-10 weight = 76.7%
| Top holdings | Weight |
|---|---|
| 15.8% | |
| 15.5% | |
| 12.6% | |
| 11.9% | |
| 5.5% | |
| 4.1% | |
| 3.2% | |
| 3.1% | |
| 2.6% | |
| 2.6% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
GLDU · Euronext Amsterdam
GLDM · Euronext Paris
CBGOLD · SIX Swiss Exchange
CD91 · Xetra (Deutsche Börse)
+ 6 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU2611731824
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU2611731824
Series, distributions, holdings and documents refresh daily.
Sheet produced on 20 October 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · CD91 · LU26117318242